Annual Industry Ranking And Forecast
Navigate through In Vivo features from around the globe. Read more about how the war in Ukraine is impacting pharma, the IRA bill is faring in the US, and how mRNA vaccines are being produced in South Africa. Also check on how companies in the Asia Pacific have been progressing with the Scrip Asia 100 data set of prescription sales from 2021.
In the last 10 years, APAC has become a hotspot for clinical trials: the region contributed almost 50% of new clinical trial activity globally in 2021.
Big pharma appears to be resetting operations in India fueling some concerns of waning interest. In Vivo looks at what the realignment means or doesn’t.
Notable new entrants moved into the Asia 100 this year, with growth catalyzed by COVID-19 vaccines.
Scrip takes a look at the current landscape in the South Korean digital therapeutics sector, where some remaining gaps in regulation and reimbursement are seen but multiple products are now progressing through pivotal local clinical trials.
The Asia 100 ranking is based on Citeline’s analysis of fiscal year 2021 prescription sales data. For more information contact: [email protected].
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.